Profile data is unavailable for this security.
About the company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
- Revenue in HKD (TTM)372.55m
- Net income in HKD-1.60bn
- Incorporated2009
- Employees1.49k
- LocationCanSino Biologics IncWest District Biomedical Park, No. 185South Avenue, West District, EconomicTIANJIN 300457ChinaCHN
- Phone+86 2 258213766
- Fax+86 2 258213626
- Websitehttp://www.cansinotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
New Horizon Health Ltd | 1.47bn | 119.39m | 6.47bn | 1.04k | 59.19 | 2.01 | 41.63 | 4.40 | 0.2389 | 0.2389 | 3.22 | 7.04 | 0.4536 | 2.16 | 2.08 | 1,674,230.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
Tong Ren Tang Technologies Co Ltd | 7.31bn | 636.98m | 6.85bn | 4.10k | 10.76 | 0.9215 | 5.01 | 0.9373 | 0.4973 | 0.4973 | 5.71 | 5.81 | 0.5212 | 0.9835 | 5.68 | 1,782,621.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
China Shineway Pharmaceutical Group Ltd | 4.87bn | 1.05bn | 6.90bn | 3.44k | 6.02 | 0.9084 | 5.63 | 1.41 | 1.39 | 1.39 | 6.45 | 9.18 | 0.5073 | 1.44 | 6.31 | 1,418,700.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
Everest Medicines Ltd | 135.92m | -911.42m | 7.21bn | 432.00 | -- | 1.32 | -- | 53.03 | -2.92 | -2.92 | 0.4342 | 16.79 | 0.0203 | 2.25 | 4.57 | 314,622.90 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 8.24bn | 798.00 | 15.24 | 2.13 | 12.24 | 5.40 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
Yichang Hec Changjiang Pharmactcl Co Ltd | 6.79bn | 2.15bn | 8.39bn | 4.62k | 3.90 | 0.9791 | 3.46 | 1.23 | 2.44 | 2.44 | 7.72 | 9.73 | 0.5111 | 3.62 | 4.09 | 1,471,130.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 8.57bn | 1.62k | -- | 2.18 | -- | 6.69 | -1.16 | -1.16 | 1.06 | 3.25 | -- | -- | -- | 789,175.90 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
Lepu Biopharma Co Ltd | 243.22m | -23.85m | 8.79bn | 429.00 | -- | 8.81 | 112.95 | 36.15 | -0.0144 | -0.0144 | 0.1466 | 0.5833 | 0.0917 | 1.06 | 1.62 | 566,946.40 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
Cansino Biologics Inc | 372.55m | -1.60bn | 8.92bn | 1.49k | -- | 0.9395 | -- | 23.93 | -6.49 | -6.49 | 1.51 | 23.04 | 0.0332 | 2.37 | 0.4619 | 249,365.00 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
InnoCare Pharma Ltd | 797.10m | -681.32m | 9.19bn | 1.09k | -- | 1.06 | -- | 11.53 | -0.404 | -0.404 | 0.4724 | 4.38 | 0.073 | 1.39 | 3.39 | 731,951.50 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
Keymed Biosciences Inc | 382.17m | -387.85m | 9.69bn | 897.00 | -- | 3.01 | -- | 25.36 | -1.49 | -1.49 | 1.45 | 11.52 | 0.0906 | 0.7314 | 26.14 | 426,054.60 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
Shanghai Henlius Biotech Inc | 5.82bn | 589.31m | 10.24bn | 3.64k | 17.43 | 4.33 | 10.48 | 1.76 | 1.08 | 1.08 | 10.67 | 4.35 | 0.5731 | 1.95 | 9.10 | 1,600,954.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
Luye Pharma Group Ltd | 6.63bn | 574.84m | 10.72bn | 5.27k | 18.56 | 0.7927 | 8.00 | 1.62 | 0.1536 | 0.1536 | 1.78 | 3.60 | 0.247 | 2.42 | 3.60 | 1,258,095.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
SciClone Pharmaceuticals (Holdings) Ltd | 3.41bn | 1.21bn | 11.68bn | 1.05k | 9.99 | 3.18 | 8.54 | 3.43 | 1.86 | 1.86 | 5.24 | 5.84 | 0.7585 | 3.56 | 3.83 | 3,243,639.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 33.70 | 0.01 | 22.98 | 14.76 | 17.50 | 31.16 | 15.96 | 25.65 | -- |
Data as of Jun 07 2024. Currency figures normalised to CanSino Biologics Inc's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 09 May 2024 | 3.25m | 2.45% |
BlackRock Fund Advisorsas of 29 Nov 2022 | 2.88m | 2.17% |
DSM Capital Partners LLCas of 31 Mar 2023 | 1.38m | 1.04% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.28m | 0.96% |
Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 944.00k | 0.71% |
Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 893.52k | 0.67% |
BlackRock Advisors (UK) Ltd.as of 29 Nov 2022 | 879.00k | 0.66% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 724.00k | 0.55% |
BlackRock (Netherlands) BVas of 29 Nov 2022 | 678.69k | 0.51% |
BlackRock Japan Co. Ltd.as of 29 Nov 2022 | 541.22k | 0.41% |
More ▼
Data from 31 Dec 2023 - 06 Jun 2024Source: FactSet Research Systems Inc.